Eli Lilly and Company Resolves Investigation Involving Numerous States
Friday, October 31st, 2008Resolution Seen as Best Option for Company and Patients Who Rely on Zyprexa
INDIANAPOLIS, Ind., Oct. 7 /PRNewswire-FirstCall/ — Eli Lilly and Company (NYSE:LLY) today announced that it has resolved a multi-state investigation involving 32 states and the District of Columbia (DC) related to the sales, marketing and promotion of its antipsychotic medication Zyprexa(R) (olanzapine).
“We believe all of the parties involved share an interest in putting this dispu…
